Joseph G Pressey MD

Pediatric Hematology & Oncology•Cincinnati, OH

Associate Professor, Cincinnati Children's Hospital Medical Center

Join to View Full Profile

3333 Burnet Ave# ML7015Cincinnati, OH 45229
Phone+1 513-636-4266
Fax+1 513-636-3549

Education & Training

Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1995 - 1998
Medical College of Georgia at Augusta UniversityClass of 1995

Certifications & Licensure

OH State Medical License 1996 - 2026
NC State Medical License 2020 - 2022
AL State Medical License 2003 - 2014
PA State Medical License 1998 - 2004
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Lane Adams Quality of Life Award American Cancer Society, 2011

Clinical Trials

Collecting and Storing Tissue From Young Patients With Cancer Start of enrollment: 2007 Mar 05
COMPLETED
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma Start of enrollment: 2006 Oct 23
Completed
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma Start of enrollment: 2005 May 30
Completed
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Apr 14
Completed
Phase 1
Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma Start of enrollment: 2011 Aug 01
Terminated
Phase 1
Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28
Completed
Phase 1, Phase 2
Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
Completed
Phase 1, Phase 2
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01
Completed
Phase 1
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2019 May 17
COMPLETED
PHASE1
Join now to see all

Publications & Presentations

PubMed

The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient.
Stephen Gilene, Lindsay Haacker, Hillary Rutan, Joseph G Pressey
Pediatric Blood & Cancer. 2025-09-01
Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome.
Stephen Gilene, Kristen D'Aquila, Brittany Cooper, Sara Szabo, Joseph G Pressey
Cancer Genetics. 2025-08-25
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors.
Filemon S Dela Cruz, Elizabeth Fox, Steven G DuBois, Gregory K Friedman, James M Croop
Pediatric Blood & Cancer. 2025-07-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Society of Pediatric Hematology-Oncology
Member
Children's Oncology Group
Member
American Association for Cancer Research - AACR
Member
Connective Tissue Oncology Society
Member

Joseph G Pressey MD

Dr. Pressey is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.